ESC Premium Access

Safety of beta-blocker discontinuation in patients after acute coronary syndromes and preserved left ventricular ejection fraction: long-term clinical outcomes from the SPUM-ACS cohort

Congress Presentation

About the speaker

Doctor Nicolas Johner

University hospitals of Geneva, Geneva (Switzerland)
0 follower

5 more presentations in this session

Effects of restrictive vs liberal transfusion strategies on mortality in patients with acute myocardial infarction and anemia: The 6-month follow up primary results of the MINT trial

Speaker: Professor T. Simon (Paris, FR)

Thumbnail

Impact of dapagliflozin on cardiometabolic outcomes after myocardial infarction according to baseline left ventricular ejection fraction: a DAPA-MI substudy

Speaker: Professor D. Erlinge (Lund, SE)

Thumbnail

Albumin creatinine index added to the grace score increases its discriminative capacity for mortality at 12 years of follow-up in patients with acute coronary syndrome

Speaker: Doctor C. Higa (Buenos Aires, AR)

Thumbnail

Microcirculatory resistance after primary percutaneous coronary intervention predicts residual myocardial damage: a post hoc analysis from the CLEVER-ACS trial

Speaker: Doctor A. Candreva (Zurich, CH)

Thumbnail

Impact of baseline thrombocytopenia on outcomes in hospitalizations for acute coronary syndrome and non-elective percutaneous coronary intervention: meta-analysis

Speaker: Doctor S. Senapati (El Paso, US)

Thumbnail

Access the full session

Risk stratification for midterm outcome after acute coronary syndromes

Speakers: Doctor N. Johner, Professor T. Simon, Professor D. Erlinge, Doctor C. Higa, Doctor A. Candreva...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations